Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
07/28/2023
"Our data suggest some patients may have an increased risk for HO-CDI as a result of the SARS-CoV-2 pandemic, which may be affected by hospitals’ patient case mix," said researchers. 
"Our data suggest some patients may have an increased risk for HO-CDI as a result of the SARS-CoV-2 pandemic, which may be affected by hospitals’ patient case mix," said researchers. 
"Our data suggest some patients...
07/28/2023
First Report Managed Care
News
09/26/2023
“It is unclear why pets appear to only infrequently acquire C difficile from their owners,” researchers wrote. “It may be that the canine gut microbiota is better able to provide colonization resistance against C difficile, even when in an...
“It is unclear why pets appear to only infrequently acquire C difficile from their owners,” researchers wrote. “It may be that the canine gut microbiota is better able to provide colonization resistance against C difficile, even when in an...
“It is unclear why pets appear...
09/26/2023
First Report Managed Care
News
06/11/2024
Treatment with nirmatrelvir-ritonavir did not significantly shorten the time to sustained alleviation of symptoms in patients with COVID-19 compared with placebo, according to a study published in The New England Journal of Medicine.
Treatment with nirmatrelvir-ritonavir did not significantly shorten the time to sustained alleviation of symptoms in patients with COVID-19 compared with placebo, according to a study published in The New England Journal of Medicine.
Treatment with...
06/11/2024
Integrated Healthcare Executive
News
02/23/2023
A Class II recall is active for a beta-blocker that failed to meet dissolution specifications.
A Class II recall is active for a beta-blocker that failed to meet dissolution specifications.
A Class II recall is active for...
02/23/2023
Pharmacy Learning Network
05/17/2016
Effects of forced vital capacity decline and suspected early acute idiopathic pulmonary fibrosis exacerbation on utilization and outcomes were recently discussed.
Effects of forced vital capacity decline and suspected early acute idiopathic pulmonary fibrosis exacerbation on utilization and outcomes were recently discussed.
Effects of forced vital capacity...
05/17/2016
First Report Managed Care
News
06/18/2021
“With proper training and education,” researchers wrote, “pharmacists are unique in improving vaccination services and public health in general.”
“With proper training and education,” researchers wrote, “pharmacists are unique in improving vaccination services and public health in general.”
“With proper training and...
06/18/2021
Pharmacy Learning Network
News
07/26/2021
According to study findings, weekly dance training stalled the progression of motor and nonmotor symptoms over 3 years in a small group of patients with mild to moderate Parkinson disease.
According to study findings, weekly dance training stalled the progression of motor and nonmotor symptoms over 3 years in a small group of patients with mild to moderate Parkinson disease.
According to study findings,...
07/26/2021
Annals of Long-Term Care
News
08/26/2021
The FDA has issued a Class II recall for more than 37,000 bottles of a prescription medication used to treat muscle spasms.
The FDA has issued a Class II recall for more than 37,000 bottles of a prescription medication used to treat muscle spasms.
The FDA has issued a Class II...
08/26/2021
Pharmacy Learning Network
News
09/23/2021
Rhodes Pharmaceuticals is recalling oxycodone hydrochloride tablets because a hydrochlorothiazide-lisinopril tablet was found in a bottle.
Rhodes Pharmaceuticals is recalling oxycodone hydrochloride tablets because a hydrochlorothiazide-lisinopril tablet was found in a bottle.
Rhodes Pharmaceuticals is...
09/23/2021
Pharmacy Learning Network
News
10/19/2021
Six weeks of daily lumateperone significantly improved depressive symptoms in patients with bipolar disorder experiencing a major depressive episode, study finds.
Six weeks of daily lumateperone significantly improved depressive symptoms in patients with bipolar disorder experiencing a major depressive episode, study finds.
Six weeks of daily lumateperone...
10/19/2021
Psychiatry & Behavioral Health